Membranous Nephropathy
New membranous nephropathy study findings have been reported by researchers at Brussels Free University
Published in Hepatitis Weekly, September 15th, 2008
"HBV-related membranous nephropathy (MN) may lead to renal failure in 1/3 of the patients and spontaneous remission is rare. There is no standard therapy for HBV-associated MN," wrote M. Mesquita and colleagues, Brussels Free University.
The researchers concluded: "We report a case of a 28-year-old man with HBV-associated MN due to pre-core HBV mutant with complete remission under an ongoing 7-year lamivudine monotherapy."
Mesquita and colleagues published their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-09-15)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Findings from C.L. Fan and co-researchers advance knowledge in acute hepatitis - Acute Hepatitis
Researchers at Nagoya University release new data on acute hepatitis - Hepatitis B Virus
Data from P. Turelli and colleagues advance knowledge in hepatitis B virus - Hepatitis B Virus
New findings from Osaka City University, Medical Department describe advances in hepatitis B virus - Hepatitis B Virus
New hepatitis B virus study findings recently were reported by Y.B. Tang and co-researchers - Hepatitis B Virus
New hepatitis B virus study findings reported from Gifu University, Medical Department - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
